Patents by Inventor Thomas G. Rehberger
Thomas G. Rehberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10834942Abstract: The invention is directed to compositions and methods are disclosed for improving production of swine. In one embodiment the composition may include a combination of at least one of a biologically pure culture of Bacillus strains. The composition may comprise a Saccharomyces cerevisiae yeast product. Methods are disclosed for providing beneficial effects to swine and their offspring, including but not limited to improved performance of the swine.Type: GrantFiled: April 11, 2018Date of Patent: November 17, 2020Assignee: Church & Dwight Co., Inc.Inventors: Mari Ellen Davis, Kim Friesen, Thomas G. Rehberger, Ran Song
-
Publication number: 20190060377Abstract: The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response resulting from ingestion of mycotoxins. In one embodiment, the strains are Bacillus strains. In another embodiment, the strains are lactic acid bacteria.Type: ApplicationFiled: October 10, 2018Publication date: February 28, 2019Inventors: MARI ELLEN DAVIS, JOSHUA REHBERGER, KIMBERLEY NOVAK, THOMAS G. REHBERGER
-
Publication number: 20180289038Abstract: The invention is directed to compositions and methods are disclosed for improving production of swine. In one embodiment the composition may include a combination of at least one of a biologically pure culture of Bacillus strains. The composition may comprise a Saccharomyces cerevisiae yeast product. Methods are disclosed for providing beneficial effects to swine and their offspring, including but not limited to improved performance of the swine.Type: ApplicationFiled: April 11, 2018Publication date: October 11, 2018Inventors: Mari Ellen Davis, Kim Friesen, Thomas G. Rehberger, Ran Song
-
Publication number: 20180092950Abstract: The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response resulting from ingestion of mycotoxins. In one embodiment, the strains are Bacillus strains. In another embodiment, the strains are lactic acid bacteria.Type: ApplicationFiled: December 15, 2017Publication date: April 5, 2018Inventors: MARI ELLEN DAVIS, JOSHUA REHBERGER, KIMBERLEY NOVAK, THOMAS G. REHBERGER
-
Patent number: 9402871Abstract: TRFs useful for identifying strains of interest are provided. A method of identifying one or more strain that can be used as a direct-fed microbial is also provided. One or more strain identified by the method is additionally provided. A method is also provided for administering to an animal an effective amount of the one or more strain. Additionally provided is an isolated strain chosen from at least one of Lactobacillus acidophilus strain P1B c6 (NRRL B-50103), Lactobacillus salivarius strain o246e 33w (NRRL B-50102), Pediococcus acidilactici strain o246e 42 (NRRL B-50171), and Pediococcus acidilactici strain P1J e3 (NRRL B-50101). An isolated strain having all of the identifying characteristics of one of the strains listed above is also provided. One or more strain can be administered as a direct-fed microbial to an animal. Methods of preparing a direct-fed microbial are also provided.Type: GrantFiled: March 18, 2015Date of Patent: August 2, 2016Assignees: DuPont Nutrition Biosciences APS, Board of Trustees of the University of ArkansasInventors: Mari Ellen Davis, Joshua M. Rehberger, Charles Maxwell, Thomas G. Rehberger, Mike King
-
Publication number: 20150306154Abstract: The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the gastrointestinal inflammatory response resulting from ingestion of mycotoxins. In one embodiment, the strains are Bacillus strains. In another embodiment, the strains are lactic acid bacteria.Type: ApplicationFiled: January 14, 2015Publication date: October 29, 2015Applicant: DUPONT NUTRITION BIOSCIENCES APSInventors: Mari Ellen Davis, Joshua Rehberger, Kimberly Novak, Thomas G. Rehberger
-
Publication number: 20150250831Abstract: Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne to the pig. The Bacillus strains also are useful when administered to herds lacking symptoms of Clostridium infection. Administration of the Bacillus strains improves performance of female breeding stock and in piglets borne by the female breeding stock.Type: ApplicationFiled: March 16, 2015Publication date: September 10, 2015Applicant: DUPONT NUTRITION BIOSCIENCES APSInventors: Thomas G. Rehberger, Mari Ellen Davis, Ashley Baker
-
Publication number: 20150190436Abstract: TRFs useful for identifying strains of interest are provided. A method of identifying one or more strain that can be used as a direct-fed microbial is also provided. One or more strain identified by the method is additionally provided. A method is also provided for administering to an animal an effective amount of the one or more strain. Additionally provided is an isolated strain chosen from at least one of Lactobacillus acidophilus strain P1B c6 (NRRL B-50103), Lactobacillus salivarius strain o246e 33w (NRRL B-50102), Pediococcus acidilactici strain o246e 42 (NRRL B-50171), and Pediococcus acidilactici strain P1J e3 (NRRL B-50101). An isolated strain having all of the identifying characteristics of one of the strains listed above is also provided. One or more strain can be administered as a direct-fed microbial to an animal. Methods of preparing a direct-fed microbial are also provided.Type: ApplicationFiled: March 18, 2015Publication date: July 9, 2015Applicant: DUPONT NUTRITION BIOSCIENCES APSInventors: Mari Ellen Davis, Joshua M. Rehberger, Charles Maxwell, Thomas G. Rehberger, Mike King
-
Patent number: 9011836Abstract: Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne to the pig. The Bacillus strains also are useful when administered to herds lacking symptoms of Clostridium infection. Administration of the Bacillus strains improves performance of female breeding stock and in piglets borne by the female breeding stock.Type: GrantFiled: July 9, 2013Date of Patent: April 21, 2015Assignee: DuPont Nutrition Biosciences ApSInventors: Thomas G. Rehberger, Mari Ellen Davis, Ashley Baker
-
Patent number: 9011877Abstract: TRFs useful for identifying strains of interest are provided. A method of identifying one or more strain that can be used as a direct-fed microbial is also provided. One or more strain identified by the method is additionally provided. A method is also provided for administering to an animal an effective amount of the one or more strain. Additionally provided is an isolated strain chosen from at least one of Lactobacillus acidophilus strain P1B c6 (NRRL B-50103), Lactobacillus salivarius strain o246e 33w (NRRL B-50102), Pediococcus acidilactici strain o246e 42 (NRRL B-50171), and Pediococcus acidilactici strain P1J e3 (NRRL B-50101). An isolated strain having all of the identifying characteristics of one of the strains listed above is also provided. One or more strain can be administered as a direct-fed microbial to an animal. Methods of preparing a direct-fed microbial are also provided.Type: GrantFiled: October 9, 2013Date of Patent: April 21, 2015Assignee: Dupont Nutrition Biosciences APSInventors: Mari Ellen Davis, Joshua M. Rehberger, Charles Maxwell, Thomas G. Rehberger, Mike King
-
Patent number: 8999318Abstract: A composition is provided that includes Bacillus subtilis 2084 (NRRL B-50013) or a strain having all of the identifying characteristics of the Bacillus subtilis 2084 (NRRL B-50013), B. subtilis 27 (NRRL B-50105) or a strain having all of the identifying characteristics of the B. subtilis 27 (NRRL B-50105), and B. licheniformis 21 (NRRL B-50134) or a strain having all of the identifying characteristics of the B. licheniformis 21 (NRRL B-50134). Animal bedding that includes the Bacillus strains is also provided, as well as a method of making the animal bedding. Also provided are methods of controlling odors from animal waste. A method of making a composition including the Bacillus strains is also provided.Type: GrantFiled: March 1, 2013Date of Patent: April 7, 2015Assignee: Dupont Nutrition Biosciences APSInventors: Marianne Cain Bellot, Keith J. Mertz, Thomas G. Rehberger
-
Patent number: 8722058Abstract: Bacillus strains that inhibit pathogenic swine E. coli and/or improve performance are provided. Inhibition of pathogenic swine E. coli decreases E. coli disease. At least one strain enhanced swine performance by improving average daily gain, feed efficiency, and feed intake. Preferred Bacillus strains are of species that are included on the GRAS, i.e., generally recognized as safe, list. Bacillus species are sporeformers and therefore are highly stable and can be fed to swine.Type: GrantFiled: June 12, 2012Date of Patent: May 13, 2014Assignee: DuPont Nutrition Biosciences ApSInventors: Thomas G. Rehberger, Dorrie S. Jordan-Parrott
-
Publication number: 20140120137Abstract: TRFs useful for identifying strains of interest are provided. A method of identifying one or more strain that can be used as a direct-fed microbial is also provided. One or more strain identified by the method is additionally provided. A method is also provided for administering to an animal an effective amount of the one or more strain. Additionally provided is an isolated strain chosen from at least one of Lactobacillus acidophilus strain P1B c6 (NRRL B-50103), Lactobacillus salivarius strain o246e 33w (NRRL B-50102), Pediococcus acidilactici strain o246e 42 (NRRL B-50171), and Pediococcus acidilactici strain P1J e3 (NRRL B-50101). An isolated strain having all of the identifying characteristics of one of the strains listed above is also provided. One or more strain can be administered as a direct-fed microbial to an animal. Methods of preparing a direct-fed microbial are also provided.Type: ApplicationFiled: October 9, 2013Publication date: May 1, 2014Inventors: Mari Ellen Davis, Joshua M. Rehberger, Charles Maxwell, Thomas G. Rehberger, Mike King
-
Publication number: 20140010792Abstract: Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne to the pig. The Bacillus strains also are useful when administered to, herds lacking symptoms of Clostridium infection. Administration of the Bacillus strains improves performance of female breeding stock and in piglets borne by the female breeding stock.Type: ApplicationFiled: July 9, 2013Publication date: January 9, 2014Applicant: DUPONT NUTRITION BIOSCIENCES APSInventors: Thomas G. Rehberger, Mari Ellen Davis, Ashley Baker
-
Patent number: 8557234Abstract: A method of controlling foam in a manure pit. In the method, one or more Bacillus strain(s) is administered in an effective amount to animals whose manure is stored in the manure pit. Also provided is a method of controlling foam in a manure storage unit. In the method, one or more Bacillus strain(s) is administered in an effective amount to the manure storage unit.Type: GrantFiled: May 18, 2011Date of Patent: October 15, 2013Assignee: DuPont Nutrition Biosciences ApSInventors: Mari Ellen Davis, Terry D. Parrott, Joshua M. Rehberger, Thomas G. Rehberger, Ardean Veldkamp, Daniel Petri
-
Patent number: 8540981Abstract: The present invention relates to a composition including Bacillus subtilis strains 3A-P4 ATCC Accession No. PTA-6506, 22C-P1 ATCC Accession No. PTA-6508, and LSSA01 NRRL Accession No. NRRL B-50104. The present invention also relates to a method of administering an effective amount of a composition comprising Bacillus subtilis strains 3A-P4 ATCC Accession No. PTA-6506, 22C-P1 ATCC Accession No. PTA-6508, and LSSA01 NRRL Accession No. NRRL B-50104 to a calf.Type: GrantFiled: July 7, 2009Date of Patent: September 24, 2013Assignee: DuPont Nutrition Biosciences ApSInventors: Christopher A. Wehnes, Keith J. Mertz, Mari Ellen Davis, Alexandra Helena Smith, Thomas G. Rehberger
-
Patent number: 8506951Abstract: Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne to the pig. The Bacillus strains also are useful when administered to herds lacking symptoms of Clostridium infection. Administration of the Bacillus strains improves performance of female breeding stock and in piglets borne by the female breeding stock.Type: GrantFiled: August 18, 2011Date of Patent: August 13, 2013Assignee: DuPont Nutrition Biosciences ApSInventors: Thomas G. Rehberger, Mari Ellen Davis, Ashley Baker
-
Patent number: 8444966Abstract: An isolated microorganism comprising a Propionibacteria strain is described. When the microorganism is fed to a ruminant, protein and fat levels in milk produced by the ruminant are increased, while body condition and milk production levels are maintained. When fed to the ruminant, the microorganism also has positive effects on various metabolic hormones and metabolites, e.g, an increase in energy balance, plasma non-esterified fatty acids levels, and plasma leptin level. Supplementation with propionibacteria reduced dry matter intake but did not affect milk production in the cows. Therefore, the propionibacteria of the invention made the cows more energy efficient as cows produced the same amount of milk, yet consumed less dry matter.Type: GrantFiled: August 18, 2011Date of Patent: May 21, 2013Assignee: DuPont Nutrition Biosciences ApSInventors: Thomas G. Rehberger, John P. O'Neill
-
Patent number: 8420074Abstract: Lactobacillus strains that have a genetic Profile I based on Apa I, Not I, and Xba I digests are provided. Preferably, the strains decrease level of at least one of coliforms and E. coli within the gastrointestinal tract of an animal. A direct-fed microbial that includes the strain is additionally provided. A method of feeding an animal the strain and a method of forming a direct fed microbial that includes the strain is also provided.Type: GrantFiled: June 14, 2012Date of Patent: April 16, 2013Assignee: DuPont Nutrition Biosciences ApSInventors: Thomas G. Rehberger, Charles V. Maxwell
-
Patent number: 8404227Abstract: A composition is provided that includes Bacillus subtilis 2084 (NRRL B-50013) or a strain having all of the identifying characteristics of the Bacillus subtilis 2084 (NRRL B-50013), B. subtilis 27 (NRRL B-50105) or a strain having all of the identifying characteristics of the B. subtilis 27 (NRRL B-50105), and B. licheniformis 21 (NRRL B-50134) or a strain having all of the identifying characteristics of the B. licheniformis 21 (NRRL B-50134). Animal bedding that includes the Bacillus strains is also provided, as well as a method of making the animal bedding. Also provided are methods of controlling odors from animal waste. A method of making a composition including the Bacillus strains is also provided.Type: GrantFiled: August 18, 2011Date of Patent: March 26, 2013Assignee: DuPont Nutrition Biosciences ApSInventors: Marianne Cain Bellot, Keith J. Mertz, Thomas G. Rehberger